Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Internal Medicine Alert

RSS  

Articles

  • Cardiopulmonary Resuscitation on the Wards: Who Survives?

    In this review of outcomes from cardiopulmonary resuscitation among non-ICU inpatients in 3 urban teaching hospitals, no patient who had an unwitnessed cardiac arrest survived to discharge. Forty-four percent of patients with witnessed respiratory arrest returned to their homes, as compared with 13% of patients with witnessed cardiac arrest (21% for pulseless ventricular tachycardia or fibrillation, and 7% for pulseless electrical activity or asystole).
  • Clinical Briefs

    The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-Aged Men; Effects of Amlodipine Fosinopril Combination on Microalbuminuria in Hypertensive Type 2 Diabetic Patients; Relation Between Alcohol Consumption and C-Reactive Protein Levels in the Adult United States Population
  • Suspected Pulmonary Embolism in Pregnancy

    Ventilation/perfusion scanning appears to be safe and effective, at least in ruling out significant clinical pulmonary embolism in pregnant patients. However, prospective studies over longer time periods should be undertaken to validate these conclusions.
  • Clinical Briefs

    Diuretics, Mortality, and Nonrecovery of Renal Function in Acute Renal Failure; Nut and Peanut Butter Consumption and Risk of Type 2 Diabetes in Women; Optimal Diets for Prevention of CHD
  • Pharmacology Watch: FDA Approves Claritin For OTC Use For Seasonal Rhinitis

    After years of legal wrangling, the FDA has approved loratadine (Claritin, Schering-Plough) as an over-the-counter (OTC) product for the treatment of seasonal rhinitis.
  • C-Reactive Protein Makes It to Center Stage

    C-reactive protein levels are stronger predictors of first cardiovascular events than low-density lipoprotein cholesterol levels.
  • Fluoroquinolones and Tendinopathies

    The excess risk of Achilles tendon disorders attributable to fluoroquinolone use was estimated to be 3.2 cases per 1000 patient-years, with most of that increase accounted for by patients 60 years of age and older who concomitantly receive corticosteroids.
  • Pharmacology Update: Atomoxetine HCl — New Drug for ADHD

    The FDA has approved Atomoxetine (previously named tomoxetine), the first nonstimulant/noncontrolled drug to be approved for the treatment of attention-deficit/hyperactivity disorder (ADHD).
  • ECG Review: Best Obtainable Tracing

    The tracing in the Figure was obtained from a 59-year-old woman with a long history of smoking. She presented with acute dyspnea and atypical chest pain. Because of moderate respiratory difficulty, this was the best quality tracing obtainable. In full acknowledgment of its suboptimal technical quality, how would you interpret this ECG? What findings may be of potential concern?
  • Doctor, I’m Dizzy!

    Dizziness and vertigo are among the most common complaints seen by neurologists, and benign paroxysmal positional vertigo is one of their most frequent causes.